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Hailing Hsu, Hong-Bing Shu, Ming-Gui Pan, whereas the 23 kDa FADD (Boldin et al., 1995a; Chinnai-
yan et al., 1995) and the 74 kDa RIP (Stanger et al., 1995)and David V. Goeddel
interact with Fas. In fact, death domains now appearTularik, Incorporated
to define interaction domains that are capable of both270 East Grand Avenue
homotypic and heterotypic associations (Song et al.,South San Francisco, California 94080
1994; Boldin et al., 1995a, 1995b; Hsu et al., 1995; Chin-
naiyan et al., 1995; Stanger et al., 1995). These observa-
tions suggest that death domains may function as adap-Summary
tors to couple some members of the TNFR superfamily
(at least TNFR1 and Fas) to other signaling proteins.Tumor necrosis factor (TNF) can induce apoptosis and
TRADD contains an N-terminal region of unknownactivate NF-kB through signaling cascades emanating
function and a C-terminal death domain that is 23%from TNF receptor 1 (TNFR1). TRADD is a TNFR1-
identical to the death domain of TNFR1. TRADD mayassociated signal transducer that is involved in acti-
play an obligatory role in TNFR1 responses, since itsvating both pathways. Here we show that TRADD
overexpression activates TNFR1-like signaling path-directly interacts with TRAF2 and FADD, signal trans-
ways for both apoptosis and activation of the transcrip-ducers that activate NF-kB and induce apoptosis, re-
tion factor NF-kB (Hsu et al., 1995). Similarly, overex-spectively. A TRAF2 mutant lacking its N-terminal
pression of FADD (Boldin et al., 1995a; Chinnaiyan et al.,RING finger domain is a dominant-negative inhibitor
1995) or RIP (Stanger et al., 1995) mimics Fas activation,of TNF-mediated NF-kB activation, but does not affect
leading to programmed cell death. However, the mecha-TNF-induced apoptosis. Conversely, a FADD mutant
nisms of signaling by TRADD, FADD, and RIP are notlacking its N-terminal 79 amino acids is a dominant-
identical. Whereas the induction of cell death by TRADDnegative inhibitor of TNF-induced apoptosis, but does
or RIP requires only their death domains, apoptosis in-not inhibit NF-kB activation. Thus, these two TNFR1±
duced by FADD overexpression occurs independentlyTRADD signaling cascades appear to bifurcate at
of its C-terminal death domain. This suggests that FADDTRADD.
contains a ªdeath effectorº domain at its N-terminus,
which may bind downstream apoptosis-signaling mole-
Introduction cules for recruitment to Fas via death domain interac-
tions.
Tumor necrosis factor (TNF) is a proinflammatory cyto- The second family of signal transducing proteins uti-
kine whose pleiotropic biological properties are signaled lized by the TNFR superfamily are the TNFR-associated
through two distinct cell surface receptors (reviewed by factors (TRAFs). TRAF1 and TRAF2 were biochemically
Tartaglia and Goeddel, 1992; Rothe et al., 1992). TNF purified as TNFR2-associated proteins of 45 and 56 kDa,
receptor 1 (TNFR1; 55±60 kDa) and TNFR2 (75±80 kDa) respectively (Rothe et al., 1994). TRAF1 and TRAF2 exist
are expressed on most cell types and are z30% identi- in a multimeric complex that interacts via TRAF2 with
cal in their extracellular, cysteine-rich, ligand-binding the signaling domains of both TNFR2 and CD40 (Rothe
regions (Loetscher et al., 1990; Schall et al., 1990; Smith et al., 1994, 1995). TRAF3 was identified by two-hybrid
et al., 1990). This extracellular domain architecture is interaction cloning as a CD40-associated protein of 64
characteristic of the larger TNFR superfamily, whose kDa (Hu et al., 1994; Cheng et al., 1995; Mosialos et al.,
members include the Fas antigen, CD27, CD30, CD40, 1995; Sato et al., 1995). The three known TRAFs share
and several other receptors (reviewed by Smith et al., a highly conserved C-terminal ªTRAF domainº of about
1994). With the exception of TNFR1 and Fas, both of 150 amino acids, which is involved in oligomerization
which can induce programmed cell death through a and receptor association (Rothe et al., 1994, 1995;
shared z80 amino acid ªdeath domainº of 28% identity Cheng et al., 1995; Sato et al., 1995). Overexpression of
(Tartaglia et al., 1993a; Itoh and Nagata, 1993), the cyto- TRAF2, butnot TRAF1or TRAF3, activates NF-kB (Rothe
plasmic domains of receptors in this superfamily share et al., 1995). Furthermore, a truncated TRAF2 lacking
no obvious sequence similarities. its N-terminal RING finger acts as a dominant-negative
Until recently, the molecular mechanisms utilized by inhibitor of NF-kB activation mediated by both TNFR2
members of the TNFR family to generate cellular re- and CD40 (Rothe et al., 1995). Therefore, TRAF2 is a
sponses have remained largely undefined. However, common mediator of signal transduction by TNFR2 and
during thepast year an improved understanding of these CD40 and, perhaps, by other members of the TNFR
mechanisms has begun toemerge with the identification superfamily.
of two distinct classes of receptor-associated proteins, Two of the most important activities of TNF, apoptosis
both of which appear to couple these receptors to down- and NF-kB activation, are signaled by TNFR1 following
stream signaling cascades. its oligomerization by the trimeric TNF (Tartaglia and
Three intracellular proteins that contain death do- Goeddel, 1992). We recently reported the molecular
mains were identified through yeast two-hybrid interac- cloning and characterization of TRADD, a novel protein
tion cloning by virtue of their interactions with the death that specifically interacts with the death domain of
domains of TNFR1 and Fas. TRADD is a 34 kDa protein TNFR1 and activates signaling pathways for both of
these activities when overexpressed (Hsu et al., 1995).that interacts specifically with TNFR1 (Hsu et al., 1995),
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Figure 1. TNF Induces Association of TRADD with TNFR1
We treated U937 cells (5 3 107) with TNF for 15 min (lanes 2 and 4)
or left them untreated (lanes 1 and 3). Cell lysates were immunopre- Figure 2. Predicted Amino Acid Sequence of Murine FADD
cipitated with anti-TNFR1 monoclonal antibody 985 (lanes 3 and 4)
The amino acid sequences of murine and human FADD are aligned.or with mouse immunoglobulin G (IgG) control antibody (lanes 1 and
Identical residues are stippled The death domain of FADD extends2). Coprecipitating TRADD was detected by immunoblot analysis
from amino acids 104±177, as indicated by the brackets.using rabbit anti-TRADD antiserum. Positions of molecular mass
standards (in kilodaltons) are shown.
for NF-kB activation by these two receptors (Rothe et
al., 1994, 1995). The interaction of TRADD with TRAF2
was verified inyeast two-hybrid interaction assays usingHere we showthat under normal conditions the associa-
full-length TRAF2. TRADD was also found to interacttion of TRADD with TNFR1 is TNF dependent. We also
strongly with TRAF1, and more weakly with TRAF3, inshow that TRADD directly interacts with TRAF2 through
two-hybrid assays (data not shown).its N-terminal half and with FADD through its C-terminal
The two-hybrid screen also yielded cDNA clones en-death domain. Furthermore, dominant-negative mu-
coding full-length murine FADD and the C-terminal 126tants of TRAF2 and FADD can block TNF-mediated NF-
amino acids of murine FADD. The 205 amino acid murinekB activation and cell death, respectively. Taken to-
FADD shares 73%identity with human FADD throughoutgether, these data suggest that TNFR1 utilizes distinct
the region (amino acids 1±177) comprising the effectorTRADD-dependent mechanisms to activate signaling
and death domains, whereas the C-terminal z30 aminopathways for NF-kB activation and apoptosis.
acids are very poorly conserved (Figure 2). Since FADD
was originally identified owing to its interaction withResults
Fas (Boldin et al., 1995a; Chinnaiyan et al., 1995), we
compared the relative strength of the TRADD±FADD andInteraction of TRADD with TNFR1
Fas±FADD interactions in two-hybrid assays. These ex-Is TNF Dependent
periments indicated that FADD consistently interactsWe previously demonstrated that TRADD specifically
10- to 20-fold more strongly with TRADD than with Fasassociates with TNFR1 when both proteins are overex-
(data not shown).pressed (Hsu et al., 1995). To determine whether the
Since TRAF1, TRAF2, and FADD interact strongly withTRADD±TNFR1 interaction is physiologically relevant,
TRADD in two-hybrid tests, we performed coimmuno-we performed the following experiment using human
precipitation assays to test whether these proteinsU937 cells. Lysates from cells that had been treated
might interact in human cells. An expression vector en-with TNF for 15 min or left untreated were immunopre-
coding TRADD was transfected alone or with expressioncipitated with a nonagonistic monoclonal antibody
vectors encoding Flag epitope±tagged TRAF1, TRAF2,
directed against the extracellular domain of TNFR1.
or FADD into human embryonic kidney 293 cells. CellCoprecipitating TRADD was detected by immuoblot
extracts were immunoprecipitated using a monoclonal
analysis using a TRADD-specific polyclonal antiserum.
antibody against the Flag epitope, and coprecipitating
TRADD coprecipitated with TNFR1 only in the TNF-
TRADD was detected by Western blotting with anti-
treated cell lysates (Figure 1). Since TNF induces tri- TRADD polyclonal antibody. TRAF1, TRAF2, and FADD
merization of TNFR1, this result suggests that the re- were individually able to coprecipitate TRADD (Figure 3).
cruitment of TRADD to TNFR1 probably depends on a
properly aggregated TNFR1 cytoplasmic domain.
Mapping of TRADD±TRAF2 and TRADD±FADD
Identification of TRAF2 and FADD Interaction Domains
as TRADD-Interacting Proteins To determine the region(s) of TRADD responsible for
To identify potential downstream components of the interaction with TRAF2 and FADD, a series of N-terminal
TNFR1/TRADD signaling pathway, we used the yeast and C-terminal TRADD truncation mutants were exam-
two-hybrid system (Fields and Song, 1989) to screen ined in two-hybrid assays (Figure 4A). A C-terminal dele-
cDNA libraries for TRADD-interacting proteins. Multiple tion mutant of TRADD lacking its entire death domain
cDNA clones were obtained that encode several distinct retained TRAF2-binding activity. This demonstrated that
proteins. As expected, two classes of clones encoded the TRAF2-binding domain resides in the N-terminal half
TRADD itself or portions of the intracellular region of (amino acids 1±169) of TRADD. A further C-terminal
TNFR1. Surprisingly, many of the cDNA clones were deletion mutant (TRADD[1±106]) failed to interact with
found to encode portions of TRAF2, a protein that inter- TRAF2. In contrast, TRADD interacts with FADD through
its C-terminal death domain (amino acids 195±312). Thisacts with TNFR2 and CD40 and transduces the signal
TNFR1±TRADD Signaling Pathways
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is the same region of TRADD that is required for interac-
tion with the death domain of TNFR1 (Hsu et al., 1995).
Deletion studies on TRAF2 indicate that its TRAF-C
domain (amino acids 348±501) was sufficient for TRADD
binding (Figure 4B). Previous studies had shown that
the entire TRAF domain (amino acids 264±501) of TRAF2
can self-associate and interact with TRAF1, TNFR2, and
CD40 (Rothe et al., 1994, 1995).
TRADD Recruits TRAF Proteins to TNFR1
The interaction of TRADD with TNFR1 and TRAFs occursFigure 3. In Vivo Interaction of FADD and TRAF Proteins with
TRADD via its C-terminal death domain and N-terminal TRAF-
We transfected 293 cells (2 3 106) with the indicated combinations binding domain, respectively. Therefore, TRADD might
of expression vectors for TRADD and Flag epitope±tagged TRAF1, be able to bind simultaneously both TNFR1 and TRAFs,
TRAF2, or FADD. After 24 hr, extracts were prepared and immuno- thereby recruiting TRAFs to the TNFR1 complex. To
precipitated with an anti-Flag monoclonal antibody. Coprecipitating
explore this possibility, we cotransfected 293 cells withTRADD was detected by immunoblot analysis using polyclonal anti-
plasmids that direct the synthesis of TNFR1, TRADD,body against TRADD. Positions of molecular mass standards (in
and Flag-tagged TRAF1 or TRAF2. Cell extracts werekilodaltons) are shown.
immunoprecipitated with agonistic polyclonal antibod-
ies against the extracellular domain of TNFR1, and co-
precipitating TRAF proteins were detected by Western
blotting with an anti-Flag monoclonal antibody. In ly-
sates prepared from cells programmed for ectopic ex-
pression of TNFR1 and TRAF1 or TRAF2, antibody
against TNFR1 failed to coprecipitate TRAF proteins
(Figure 5A). This result, which suggests that no direct
interaction occurs between the TNFR1 and TRAF1 or
TRAF2, is in agreement with results obtained previously
by yeast two-hybrid interaction assays (Rothe et al.,
1995). However, when the same experiments were per-
formed on lysates from cells that also expressed
TRADD, bothTRAF1 and TRAF2were coimmunoprecipi-
tated with TNFR1 (Figure 5A). These results provide evi-
dence that TRADD can serve as an adaptor protein and
recruit TRAF1, TRAF2, or both to TNFR1.
Since TRAF2 is capable of interacting with both
TNFR2 and TRADD, we also considered the possibility
that TRAF2 could recruit TRADD to the TNFR2 receptor
complex. This was examined by cotransfection and im-
munoprecipitation experiments similar to those de-
scribed above for TNFR1. However, no ternary TNFR2±
TRADD±TRAF2 complex could be detected (data not
shown), demonstrating that TRAF2 cannot simultane-
ously bind to both TNFR2 and TRADD. This finding sug-
gests that TNFR2 and TRADD, both of which interact
with the C-terminal TRAF domain of TRAF2 (see Figure
4B; Rothe et al., 1994), compete for the same, or anFigure 4. Mapping of TRADD±TRAF2 and TRADD±FADD Interaction
overlapping, binding site on TRAF2.Domains
(A) Interaction of TRAF2 and FADD with the N- and C-terminal do-
mains of TRADD, respectively. Expression vectors encoding wild-
type TRADD or the indicated deletion mutants fused to the GAL4 TRADD Enhances Association of FADD
DNA-binding domain were cotransformed into yeast Y190 cells with with TNFR1
a GAL4 activation domain±TRAF2 or GAL4 activation domain±FADD The strong interaction between TRADD and FADD oc-
expression vector.
curs via their death domains. TRADD also associates(B) The TRAF domain of TRAF2 interacts with TRADD. Expression
with TNFR1 through death domain interactions. To de-vectors encoding wild-type TRAF2 or the indicated deletion mutants
fused to GAL4 activation domain were cotransformed into yeast termine whether TRADD can simultaneously interact
Y190 cells with a GAL4 DNA-binding domain±TRADD expression with both FADD and TNFR1 to recruit FADD to TNFR1,
vector. The TRAF domain of TRAF2 can be subdivided into two we performed coimmunoprecipitation experiments.
parts, a coiled-coil (CC) region and a C-terminal (TRAF-C) region FADD coprecipitated with Fas, consistent with previous
(Rothe et al., 1994). Transformation mixes were plated on synthetic
results (Chinnaiyan et al., 1995), whereas no detectabledextrose plates lacking tryptophan and leucine. Filter assays were
FADD coprecipitated with TNFR1 (Figure 5B). In con-performed for b-galactosidase activity. Plus signs represent blue
color development; minus signs indicate no color development. trast, when TNFR1 and FADD were expressed in the
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in the TNFR1 complex suggests that it may also be
involved in signaling TNFR1 responses. However, our
previous experiments using a dominant-negative muta-
tion of TRAF2 lacking the N-terminal 86 amino acids
that comprise the RING finger domain (TRAF2[87±501])
failed to demonstrate a role for TRAF2 in TNFR1-initiated
NF-kB activation (Rothe et al., 1995). To examine further
a potential role for TRAF2 in NF-kB activation by TNFR1,
we selected the 293 cell line, since electrophoretic mo-
bility shift assays have shown that TNF activates NF-kB
exclusively through endogenous TNFR1 in these cells
(Rothe et al., 1995).
We reasoned that our earlier failure to see an effect
of TRAF2(87±501) on signaling through endogenous
TNFR1 might be related to the stability of the TNFR1±
TRADD±TRAF complex. In those experiments, TNF stim-
ulation had been performed shortly after transfection,
perhaps before the newly synthesized TRAF2(87±501)
could displace endogenous TRAF1/TRAF2 from the
complex. Therefore, we performed a time course experi-
ment in which TNF was added at various times following
TRAF2(87±501) transfection (Figure 6). We found that
293 cells transfected with a control expression vector
responded to TNF with an approximately 20-fold in-
crease in NF-kB reportergene activity. When TNF stimu-
lation was performed 16 hr after transfection with the
TRAF2(87±501) expression vector, NF-kB activation was
only partially compromised (approximately 7-fold acti-Figure 5. TRADD Recruits TRAF1, TRAF2, and FADD to TNFR1
vation). However, the inhibitory effect of TRAF2(87±501)
(A) Coimmunoprecipitation of TNFR1±TRADD±TRAF complexes. We
increased with time. TRAF2(87±501) expression com-transfected 293 cells (2 3 106 per 100 mm plate) with the indicated
pletely blocked TNF-induced NF-kB activation (1.2 6combinations of expression vectors for TNFR1, TRADD, Flag±
TRAF1, or Flag±TRAF2. After 24 hr, extracts were prepared and 0.2-fold activation) when TNF treatment was performed
immunoprecipitated with preimmune serum (odd-numbered lanes) 48 hr after transfection (Figure 6). Similar results were
or with polyclonal antibody against the extracellular domain of obtained using HeLa cells (data not shown).
TNFR1 (even-numbered lanes). Coprecipitating Flag±TRAF1 and TNF and interleukin-1 (IL-1) elicit many similar biologi-
Flag±TRAF2 were detected by immunoblot analysis with anti-Flag
cal activities, including NF-kB activation in 293 cells. Tomonoclonal antibody.
determine the specificity of the observed TNF-inhibitory(B) Coimmunoprecipitation of TNFR1±TRADD±FADD complexes.
We transfected 293 cells with the indicated combinations of expres- effect of TRAF2(87±501), we compared the effect of
sion vectors for Fas, TNFR1, TRADD, Flag±FADD, TRAF1, and TRAF2(87±501) overexpression on NF-kB activation by
TRAF2. Western blotting analysis indicated that Flag±FADD expres- these two cytokines. In a dose-response experiment,
sion levels were similar in all samples (data not shown). Lysates low levels (0.1 mg) of TRAF2(87±501) expression vector
were immunoprecipitated with preimmune (lanes 1, 3, 5, and 7),
were sufficient to inhibit TNF-induced NF-kB-dependentanti-Fas (lane 2), or anti-TNFR1 (lanes 4, 6, and 8) antiserum. Coprec-
reporter activity significantly, and high levels (3.2 mg)ipitating Flag±FADD was detected with anti-Flag monoclonal an-
tibody. completely blocked activation. In contrast, overexpres-
sion of TRAF2(87±501) had no effect on IL-1-mediated
NF-kB activation (Figure 7).These results provide strong
presence of TRADD, FADDcould be detected in the anti- evidence that the TRAF2(87±501) dominant-negative
TNFR1 immune complex. However, even under these mutant is inhibiting NF-kB activation in a specific man-
conditions, the amount of FADD that coprecipitated with ner and that TRAF2 plays an important role in TNFR1
TNFR1 was less than with Fas. The addition of TRAF1 signaling.
and TRAF2 did not inhibit, but rather slightly enhanced,
the ability of TRADD to recruit FADD to TNFR1 (Figure
5B). This result shows that TRADD can simultaneously The Apoptotic Pathway Activated by TNFR1
Does Not Require TRAF2recruit TRAF proteins and FADD to TNFR1. Furthermore,
these experiments suggest that, whereas TRADD±FADD Two important activities of TNF signaled through TNFR1
are activation of NF-kB and induction of apoptosis. Ov-and TRADD±TNFR1 complexes are relatively stable, tri-
meric TNFR1±TRADD±FADD complexes may exist only erexpression of the TNFR1-associated protein TRADD
can trigger both activities by activating two distinct sig-transiently or may require other proteins for their stabili-
zation. naling pathways (Hsu et al., 1995). However, overexpres-
sion of TRAF2 activates NF-kB (Rothe et al., 1995), but
does not induce cell death (H. H. and D. V. G., unpub-NF-kB Activation by TNFR1
Requires TRAF2 lished data), suggesting that TRAF2 may not be an es-
sential component of the TNFR1±TRADD apoptotic sig-The activation of NF-kB by TNFR2 and CD40 is mediated
by TRAF2 (Rothe et al., 1995). The presence of TRAF2 naling cascade. To examine further whether TRAF2
TNFR1±TRADD Signaling Pathways
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completely blocked cell death (Table 1). Taken together,
these observations strongly support a model for signal-
ing by the TNFR1 complex in which TRAF2 is dispens-
able for apoptosis, but essential for NF-kB activation.
The Death Domain of FADD Inhibits
TNF-Induced Apoptosis
Overexpression of FADD has been shown to induce
programmed cell death (Boldin et al., 1995a; Chinnaiyan
et al., 1995). This activity requires only amino acids
1±117 of FADD (Chinnaiyan et al., 1995). Futhermore,
a FADD deletion mutant lacking amino acids 1±79
acts as a dominant-negative inhibitor of Fas-mediated
apoptosis, demonstrating that the Fas apoptotic path-
way requires FADD (V. M. Dixit, personal communica-
tion). Since FADD can directly associate with TRADD,
we considered the possibility that FADD may also partic-
ipate in TNF-induced cell death. We examined the effect
of a deletion mutant of FADD lacking its 79 N-terminal
amino acids (FADD[80±205]) on TNF-mediated killing of
HeLa cells. Overexpression of wild-type FADD, but not
FADD(80±205), was able to trigger cell death in these
cells, in accordance with previous findings (Chinnaiyan
et al., 1995). Importantly, FADD(80±205) was a potent
inhibitor of TNF-mediated apoptosis, blocking cell death
as effectively as CrmA (Table 1). Similar results were
obtained using mouse NIH 3T3 cells (data not shown).
It has been shown previously that overexpression of
either TRADD (Hsu et al., 1995) or TNFR1 (Boldin et
al., 1995b) triggers cell death, presumably through an
aggregation phenomenon that activates a TNFR1 signal-
ing cascade. However, when 293 cells (Figure 7) or HeLa
cells (data not shown) were cotransfected with the
FADD(80±205) expression vector, neither TRADD nor
TNFR1 overexpression induced cell death. The strongFigure 6. The TRAF2(87±501) Dominant-Negative Mutant Specifi-
dominant-negative effect of FADD(80±205) on cell deathcally Inhibits TNF-Induced NF-kB Activation
induced by TNF, TNFR1, and TRADD suggests that(A) Time-dependent effect of TRAF2(87±501) expression on TNF-
FADD participates in the apoptotic pathway activatedinduced NF-kB activation. We transfected 293 cells (2 3 105) with
1 mg of TRAF2(87±501) expression vector or 1 mg of pRK vector by TNF through TNFR1 and TRADD.
control, together with 1 mg of pELAM-luc reporter and 0.5 mg of
pRSV-bgal plasmids. At the indicated times following transfection,
The Death Domain of FADD Does Not Inhibitcells were either treated with TNF (20 ng/ml) or left untreated for
TNF-Mediated NF-kB Activationan additional 6 hr. The values indicated (shown as mean 6 SEM)
represent luciferase activities for TNF-treated cells relative to un- Since FADD(80±205) potently inhibits the TNFR1±
treated cells for an experiment performed in duplicate. TRADD pathway that triggers apoptosis, we asked
(B) Dose response effect of TRAF2(87±501) expression on TNF- whether it might also block the TNFR1±TRADD NF-kB
induced NF-kB activation. We transfected 293 cells (2 3 105) with
activation pathway. In a dose-response experiment,1 mg of pELAM-luc reporter, 0.5 mg of pRSV-bgal, and the indicated
FADD(80±205) overexpression failed to inhibit TNF-amounts of TRAF2(87±501) expression vector and supplemented
induced activation of an NF-kB-dependent reporterthem with pRK control vector for a total of 4.7 mg of DNA; 36 hr
after transfection, cells were treated for 6 hr with 20 ng/ml of either gene (Figure 8). In fact, when expressed at high levels,
TNF or IL-1. Values represent luciferase activities relative to the FADD(80±205) itself activates NF-kB. However, NF-kB
same cells without cytokine treatment and are shown as mean 6 activation mediated by TNF was still observed above
SEM for representative experiments performed in duplicate.
these FADD(80±205)-induced levels. FADD(80±205) also
failed to inhibit NF-kB activation triggered by overex-
pression of TRADD or TNFR1 (data not shown). Thesecontributes to apoptosis, we studied the effect of the
results suggest that FADD does not play a role in theTRAF2 dominant-negative mutant on TNF-mediated kill-
TNFR1±TRADD signaling cascade leading to NF-kB ac-ing of HeLa cells, a process which is signaled by TNFR1
tivation.(Tartaglia et al., 1993b). In this assay (Hsu et al., 1995),
cells are cotransfected with a b-galactosidase expres-
sion plasmid. The cells are treated 36 hr later with TNF Discussion
for 12 hr and then scored for cell death. Overexpression
of TRAF2(87±501) had no protective effect in these Recently, several novel proteins have been identified
that interact with members of the TNFR superfamily toassays, whereas CrmA, a known inhibitor of TNF-medi-
ated apoptosis (Tewari and Dixit, 1995; Enari et al., 1995) initiate intracellular signal transduction events (Rothe et
Cell
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Figure 7. FADD(80±205) Inhibits Apoptosis
Induced by Overexpression of TRADD and
TNFR1
We transiently transfected 293 cells (2 3 105)
with the indicated expression vectors (1 mg)
and analyzed them 24 hr later by phase-con-
trast microscopy. Scale bar is 50 mm.
al., 1994; Hu et al., 1994; Boldin et al., 1995a; Cheng et TNFR1 death domains would then provide a high affinity
binding site for TRADD, perhaps itself in a preassociatedal., 1995; Chinnaiyan et al., 1995; Hsu et al., 1995; Mo-
sialos et al., 1995; Sato et al., 1995; Stanger et al., 1995). state (Figure 9).
A yeast two-hybrid screen was performed to identifyThese signaling proteins fall into two structural classes,
containing either death domains (TRADD, FADD, and TRADD-interacting proteins as candidate signal trans-
ducers for the NF-kB and apoptotic pathways. We iso-RIP) or TRAF domains (TRAF1, TRAF2, and TRAF3). The
death domain±containing proteins are involved in signal- lated several clones encoding TRAF2, a 56 kDa protein
originally purified through its association with TNFR2ing by TNFR1 and Fas antigen, two receptors which
themselves contain death domains. Therefore, death (Rothe et al., 1994) and later shown to be a common
mediator of NF-kB activation by TNFR2 and CD40domains, in addition to their clear involvement in apop-
totic signaling, appear to define sequences involved in (Rothe et al., 1995). Thus, the two known classes of
signal transducers for the TNFR family, TRAF domainprotein±protein interactions. In contrast, the TRAF do-
main proteins interact with receptors (TNFR2 and CD40) and death domain proteins, are capable of direct inter-
action. We also isolated cDNAs encoding FADD, a deaththat have no recognizable domains or motifs. The results
of these initial cloning experiments seemed to confirm domain±containing protein previously shown to interact
with Fas and to trigger cell death when overexpressedearlier predictions (Dembic et al., 1990; Lewis et al.,
1991; Goodwin et al., 1991) that TNFR1 and TNFR2 (Boldin et al., 1995a; Chinnaiyan et al., 1995).
would be found to activate independent and distinct
signal transduction pathways. TRADD±TRAF2 Interaction and Activation
of NF-kBTRADD interacts with the death domain of TNFR1 to
initiate distinct signaling cascades for two of the most The identification of a TRADD±TRAF2 complex raised
the possibility that TRAFs might associate indirectly withimportant biological activities of TNF, NF-kB activation
and programmedcell death (Hsu et al.,1995). Our finding TNFR1 and TRADD might associate indirectly with
that this interaction is TNF dependent suggests that the
death domains of TRADD and TNFR1 do not interact
with each other as monomers. Instead, the trimeric TNF
is likely to induce trimeric or perhaps higher order aggre-
gates of TNFR1 (Banner et al., 1993) that are stabilized
by the self-associating death domain of TNFR1 (Song
et al., 1994; Boldin et al., 1995b). These aggregated
Table 1. Inhibition of TNF-Induced Apoptosis of HeLa Cells by
FADD(80±205), but Not by TRAF2(87±501)
Number of Blue Cells per Well
Expression Vector Minus TNF Plus TNF
pRK control 187 6 25 0 6 0
TRAF1 219 6 12 0 6 0
TRAF2 249 6 4 0 6 0
TRAF2(87±501) 226 6 11 0 6 0
FADD 9 6 4 0 6 0
FADD(80±205) 229 6 22 237 6 15
Figure 8. FADD(80±205) Is Not a Dominant-Negative Inhibitor ofCrmA 266 6 18 189 6 39
TNF-Induced NF-kB Activation
HeLa cells (2 3 105 cells per well) were transiently cotransfected
We transfected 293 cells (2 3 105) with 1 mg of pELAM-luc reporter,with pCMV-bgal (0.5 mg) and 2.5 mg of expression vector for TRAF1,
0.5 mg of pRSV-bgal, and the indicated amounts of FADD(80±205)TRAF2, TRAF2(87±501), FADD, FADD(80±205), or CrmA; 36 hr after
expression vector and supplemented them with pRK control vectortransfection, cells were treated with 10 mg/ml cycloheximide with
for a total of 4.7 mg of DNA; 36 hr after transfection, cells wereor without 20 mg/ml TNF for 12 hr. Data (6 SEM) are shown as the
treated for 6 hr with 20 ng/ml TNF. Values represent luciferase activi-number of blue cells per 35 mm dish for two independent transfec-
ties relative to vector-transfected cells and are shown as mean 6tions.
SEM for representative experiments performed in duplicate.
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which the two (or more) TNFR1±TRADD signal transduc-
tion pathways diverge. The TRAF2 pathway, which is
shared with TNFR2, CD40, and probably other members
of the TNFR superfamily, ultimately would result in NF-
kB activation.
On the surface, the results described here would seem
to contradict our earlier characterization of TRADD dele-
tion mutants (Hsu et al., 1995). In those experiments we
showed that a TRADD mutant (TRADD[195±312]) lacking
amino acids 1±194 was capable of activating NF-kB
when overexpressed. This result implied that the N-ter-
minal 194 amino acids of TRADD, and by inference pro-
teins such as TRAF2 that bind to this region of TRADD,
would not be required for NF-kB activation. This appar-
ent paradox can be explained by the following experi-
mental result. We have found that the NF-kB activation
pathway induced by TRADD(195±312) can be potently
inhibited by overexpression of the TRAF2(87±501) domi-
nant-negative mutant (data not shown) and is therefore
TRAF2 dependent. To date, all TRAF2-dependent path-
ways for NF-kB activation appear to require TRAF2 ag-
gregation (Rothe et al., 1995). Therefore, our current
interpretation of these data is that TRADD(195±315)
overexpression leads to aggregation of endogenous
TRADD and its associated TRAF2.
Figure 9. A Model for the Activation of Two Distinct TNFR1 Signal Many details of the molecular mechanism(s) by which
Transduction Pathways by TNF TRAF2 activates NF-kB remain a mystery. NF-kB con-
The trimeric TNF induces TNFR1 aggregation, which is stabilized sists of p50 and p65 subunits that are normally associ-
by homotypic interactions of the death domain of TNFR1. TRADD
ated with the cytoplasmic inhibitor protein IkB (Liou and(perhaps as an oligomer) associates via its own death domain with
Baltimore, 1993; Beg and Baldwin, 1993). Activation ofthe aggregated death domain of TNFR1 to initiate signaling cas-
NF-kB by the proinflammatory cytokines IL-1 and TNFcades for both apoptosis and NF-kB activation. TRAF2 and FADD
are TRADD-interacting proteins that define the NF-kB and cell death (Osborn et al., 1989) results in rapid serine phosphoryla-
pathways, respectively (see text). tion and degradation of IkB, releasing NF-kB for translo-
cation to the nucleus (Beg et al., 1993; Palombella et
al., 1994). The phosphorylation of IkB is thought to be
the cytokine-regulated step that targets IkB for degrada-TNFR2. We found that TNFR1±TRAF±TRAF complexes
tion by the constitutive ubiquitin±proteasome pathwaycan indeed exist. Conversely, TNFR2±TRADD±TRAF
(Thanos and Maniatis, 1995). In this regard, TNF hascomplexes cannot form, presumably because TNFR2
been shown to activate a TNFR1-associated serine pro-and TRADD compete for binding to similar sites in TRAF
tein kinase activity (VanArsdale and Ware, 1994). If onedomains. These findings were conceptually appealing
assumes this kinase is required for NF-kB activation byfor two reasons. First, both TNFRs are independently
TNF, then the essential role of the RING finger domaincapable of NF-kB activation (Wiegmann et al., 1992;
of TRAF2 in NF-kB activation might be to regulate kinaseLÐgreid et al., 1994; Rothe et al., 1994; Hsu et al., 1995)
activity, recruit the kinase to the TNFR1 signaling com-and association with TRAF2, a protein whose overex-
plex, or both.pression leads to NF-kB activation (Rothe et al., 1995).
Second, of the two TNFRs, only TNFR1 interacts with
the cell death±inducing protein TRADD (Hsu et al., 1995), TRADD±FADD Interaction and Signaling
and this receptor also exerts a far more dominant role of Apoptosis
in the signaling of apoptosis than does TNFR2 (Tartaglia The strong interaction observed between the death do-
et al., 1991, 1993b). mains of TRADD and FADD suggested the possibility
The role of TRAF2 in TNFR1 signaling was examined that TRADD might be able to recruit FADD to TNFR1.
by expressing TRAF2(87±501), a truncated version of Indeed, low levels of FADD were found in the TNFR1
TRAF2 lacking its N-terminal RING finger domain. This complex when FADD, TRADD, and TNFR1 were coex-
dominant-negative TRAF2 mutant can inhibit NF-kB ac- pressed, raising the question of whether FADD is in-
tivation by TNFR2 and CD40 (Rothe et al., 1995). When volved in TNFR1-mediated signaling.
overexpressed in 293 cells, TRAF2(87±501) blocked NF- To address a possible role for FADD in signal trans-
kB activation by TNF, a process that is TNFR1 depen- duction by TNFR1, we examined an N-terminal deletion
dent. NF-kB activation by the cytokine IL-1 was unaf- mutant of murine FADD obtained in our two-hybrid
fected by TRAF2(87±501), demonstrating that TRAF2 is screen. Expression of FADD(80±205) completely blocked
not involved in IL-1 signaling. TRAF2(87±501) overex- cell death induced by TNF treatment, or by overexpres-
pression also had no effect on TNF-mediated apoptosis. sion of TNFR1 or TRADD, without affecting NF-kB acti-
vation. The anti-apoptotic activity of FADD(80±205) inThis result is consistent with TRAF2 defining a point at
Cell
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Experimental Proceduresthese assays was as potent as that of CrmA and much
more potent than Bcl-2 (Hsu et al., 1995). A similarly
Reagents and Cell Linestruncated human FADD acts as a dominant-negative
Recombinant human TNF and IL-1 were provided by Genentech.
inhibitor of Fas-mediated apoptosis (V. M. Dixit, per- The rabbit anti-TNFR1, anti-Fas, and anti-TRADD antisera and the
sonal communication). Therefore, FADD may be a com- monoclonal antibody against the Myc epitope tag have been de-
ponent of the cell death pathways triggered by both scribed previously (Tartaglia et al., 1991; Wong and Goeddel, 1994;
Hsu et al., 1995). Monoclonal antibody 985 against the extracellularTNFR1 and Fas. Alternatively, FADD(80±205) may exert
domain of TNFR1 was provided by Genentech. The monoclonalits dominant-negative effect through titration of an un-
antibody against the Flag epitope was purchased from Kodak Inter-
identified component of the TNFR1 cell death pathway. national Biotechnologies. The human 293 embryonic kidney (R.
However, high level expression of FADD(80±205) did not Tjian), human HeLa derivative HtTA-1 (H. Bujard), human U937 his-
appear to interfere with TRADD binding to TNFR1 (data tiocytic lymphoma (G. Wong), and murine NIH 3T3 fibroblast (Ameri-
can Type Culture Collection) cell lines were obtained from the indi-not shown).
cated sources.The signaling of cell death by TNFR1 and Fas is not
well understood, but considerable evidence suggests
Expression Vectorsthe apoptotic pathway requires activation of a protease
Mammalian cell expression vectors encoding TNFR1, TRADD,
cascade that ultimately leads to cleavage of cell death TRAF1, TRAF2, TRAF2(87±501), and CrmA have been described
substrates (reviewed by Martin and Green, 1995). CrmA previously (Hsu et al., 1995; Rothe et al., 1995). The expression
vectors for Fas were provided by Dr. V. Dixit. The full-length FADDexpression blocks this pathway by directly binding to
and FADD(80±205) expression plasmids was prepared by insertingcysteine proteases of the CED-3/interleukin-1b-con-
a SalI±NotI fragment from the two-hybrid FADD cDNA clones in-verting enzyme (ICE) family (Tewari and Dixit, 1995; Enari
frame with an N-terminal Flag epitope in the vector pRK5. The con-
et al., 1995; Los et al., 1995). Presumably, FADD(80±205) trol expression plasmid pRK5, the NF-kB reporter plasmid pELAM-
blocks the cell death pathway at a receptor-proximal luc, and pCMV-bgal were also described previously (Hsu et al.,
step that precedes protease activation, either by dis- 1995). Restriction sites in the TRADD cDNA (StuI, SmaI, and NotI)
were used to obtain deletion mutants of TRADD (amino acids 1±274,placing FADD or by tying up other components required
1±169, and 1±106, respectively). Wild-type and deletion mutants ofto execute the death signal(s). As such, FADD(80±205)
TRADD were cloned into the yeast GAL4 DNA-binding domain vec-should be a useful reagent for dissecting apoptotic cas-
tor pGBT9 (Clontech). Plasmids containing the GAL4 activation do-
cades initiated by other events. main fused with TRAF2, TRAF2(87±501), and TRAF2(264±501) were
Apoptosis mediated by TNFR1 and Fas are similar as described previously (Rothe et al., 1994, 1995). TRAF2(348±501)/
GAL4ad was generated by cloning the appropriate coding sequencein that both signaling cascades are initiated by death
into pPC86. TRAF2(1±358)/GAL4ad was provided by Dr. H. Y. Song.domains and end in activation of ICE-like protease(s).
However, clear differences in these two cell death path-
Yeast Two-Hybrid Cloningways have been observed (Wong and Goeddel, 1994;
The plasmid GAL4bd±TRADD (Hsu et al., 1995), which encodes the
Schulze-Osthoff et al., 1994). For example, Fas-medi- GAL4 DNA-binding domain fused to full-length TRADD, was used
ated cell death occurs much more rapidly than that trig- as bait in two-hybrid screens of HeLa (Clontech) and mouse fetal
liver stromal cell (provided by L. Lasky) cDNA libraries. The isolationgered by TNFR1 (Clement and Stamenkovic, 1994; Ab-
of positive clones and subsequent two-hybrid interaction analysesreu-Martin et al., 1995). These differences might be due
were carried out as described elsewhere (Hsu et al., 1995). DNAto differential contributions from other, non-FADD com-
sequencing was performed on an Applied Biosystems model 373A
ponents of the receptor complexes. It is also possible automated DNA sequencer.
that the greater affinity of FADD for Fas than for TNFR1±
TRADD observed in our coimmunoprecipitation experi- Transfections and Reporter Assays
The 293, NIH 3T3, and HtTA-1(HeLa) cell lines were maintained inments might reflect affinity differences under physiologi-
high glucose Dulbecco's modified Eagle's medium containing 10%cal conditions. In turn, the amount of FADD present in
fetal calf serum, 100 mg/ml penicillin G, and 100 mg/ml streptomycin
the respective receptor complexes might correlate with (GIBCO). For reporter and apoptosis assays, z2 3 105 cells per well
potency of the death signal. were seeded on 6-well (35 mm) dishes. For coimmunoprecipitations,
z2 3 106 cells per well were seeded on 100 mm plates. Cells were
transfectedthe following day by thecalcium phosphate precipitation
method (Ausubel et al., 1994). Luciferase reporter assays were per-Conclusions
formed as described elsewhere (Hsu et al., 1995).The demonstration that TRADD interacts with TRAF2
and FADD, and can recruit both to TNFR1, suggested Coimmunoprecipitation and Western Blot Analysis
that TRAF2 and FADD may be involved in TNFR1± We grew U937 cells (5 3 107) in RPMI medium containing 10% fetal
TRADD-mediated signaling. That these interactions de- calf serum and 100 mg/ml each of penicillin G and streptomycin,
washed them in warm PBS, and incubated them for 15 min in thefine two distinct signaling pathways emanating from
presence or absence of TNF (100 ng/ml). Cells were lysed in 1 mlTRADD (Figure 9) is supported by the ability of TRAF2
of lysis buffer (20 mM Tris [pH 7.5], 150 mM NaCl, 1% Triton X-100,and FADD to activate NF-kB and induce apoptosis, re-
1 mM EDTA, 30 mM NaF, 2 mM sodium pyrophosphate, 10 mg/ml
spectively. This hypothesis is further strengthened by aprotinin, 10 mg/ml leupeptin). Lysates were incubated with 25 mg
the effectiveness of dominant-negative mutants at se- of monoclonal antibody 985 or mouse IgG for 2 hr at 48C, then mixed
with 25 ml of a 1:1 slurry of protein GammaBind G±Sepharose, andlectively inhibiting one pathway or the other: TRAF2(87±
incubated for another 2 hr. The Sepharose beads were washed501) blocks NF-kB activation by TNFR1 and FADD(80±
twice with 1 ml of lysis buffer, twice with 1 ml of high salt (1 M NaCl)205) blocks apoptosis. It will now be of great interest to
lysis buffer, and twice more with lysis buffer. Transfected 293 cells
identify downstream events in these signaling cascades from each 100 mm dish were lysed in 1 ml of E1A buffer (50 mM
that connect TRAF2 to IkB phosphorylation and FADD HEPES [pH 7.6], 250 mM NaCl, 0.1% NP-40, 5 mM EDTA). For each
immunoprecipitation, 0.5 ml aliquots of lysates were incubated withto cysteine protease activation.
TNFR1±TRADD Signaling Pathways
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1 ml of anti-TNFR1 or anti-Fas antibody or with 2 ml of anti-Flag receptors have similarextracellular, but distinct intracellular, domain
sequences. Cytokine 2, 231±237.antibody at 48C for at least 1 hr. The lysates were mixed with 20 ml
of a 1:1 slurry of protein A± or protein G±Sepharose (Pharmacia) Enari, M., Hug, H., and Nagata, N. (1995). Involvement of an ICE-
and incubated for another hour. The Sepharose beads were washed like protease in Fas-mediated apoptosis. Nature 375, 78±81.
twice with 1 ml of E1A buffer, twice with 1 ml of high salt (1 M NaCl)
Fields, S., and Song, O.-k. (1989). A novel genetic system to detectE1A buffer, and twice again with E1A buffer. The precipitates were
protein-protein interactions. Nature 340, 245±246.fractionated on 10% SDS±PAGE and transferred to Immobilon-P
Goodwin, R.G., Anderson, D., Jerzy, R., Davis, T., Brannan, C.I.,membrane (Millipore). Subsequent Western blotting analyses were
Copeland, N.G., Jenkins, N.A., and Smith, C.A. (1991). Molecularperformed as described elsewhere (Hsu et al., 1995).
cloning and expression of the type I and type II murine receptors
for tumor necrosis factor. Mol. Cell. Biol. 11, 3020±3026.Apoptosis Assays
Transfected HeLa cells were washed with PBS, fixed in PBS con- Hsu, H., Xiong, J., and Goeddel, D.V. (1995). The TNF receptor
taining 2% paraformaldehyde, 0.2% glutaraldehyde for 5 min at 48C, 1-associated protein TRADD signals cell death and NF-kB activa-
and washed again with PBS. Fixed cells were stained overnight with tion. Cell 81, 495±504.
PBS containing 1 mg/ml X-Gal, 5 mM potassium ferricyanide, 5 mM
Hu, M.H., O'Rourke, K., Boguski, M.S., and Dixit, V.M. (1994). A
potassium ferrocyanide, 2 mM MgCl2, 0.02% NP-40, 0.01% SDS. novel RING finger protein interacts with the cytoplasmic domain of
The number of blue-staining cells was determined microscopically.
CD40. J. Biol. Chem. 269, 30069±30072.
We analyzed 293 cells for apoptosis by phase-contrast microscopy
Itoh, N., and Nagata, S. (1993). A novel protein domain required for24 hr after transfection.
apoptosis. J. Biol. Chem. 268, 10932±10937.
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